Lanxia Zhou

1 Donggang West Road
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Drug-tolerant persister cells: the deadly survivors in hematological malignancies.

Drug-tolerant persister cells: the deadly survivors in hematological malignancies.

Journal: Frontiers in pharmacology
Published: November 05, 2025

MPN-12-NH2 shows potent antinociception effects by targeting opioid, cannabinoid, and neuropeptide FF receptors.

MPN-12-NH2 shows potent antinociception effects by targeting opioid, cannabinoid, and neuropeptide FF receptors.

Journal: Peptides
Published: August 28, 2025

Peripheral inflammation enhances opioid-induced gastrointestinal motility inhibition via up-regulating spinal mu opioid receptor.

Peripheral inflammation enhances opioid-induced gastrointestinal motility inhibition via up-regulating spinal mu opioid receptor.

Journal: Toxicology and applied pharmacology
Published: October 04, 2024

Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR.

Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR.

Journal: Anti-cancer drugs
Published: May 10, 2024

MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects.

MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects.

Journal: Neuropeptides
Published: May 07, 2024

Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies.

Multifaceted effects of LRP6 in cancer: exploring tumor development, immune modulation and targeted therapies.

Journal: Medical oncology (Northwood, London, England)
Published: March 02, 2024

The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia.

The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia.

Journal: Journal of cancer research and clinical oncology
Published: May 24, 2023

Salinomycin sodium exerts anti diffuse large B-cell lymphoma activity through inhibition of LRP6-mediated Wnt/β-catenin and mTORC1 signaling.

Salinomycin sodium exerts anti diffuse large B-cell lymphoma activity through inhibition of LRP6-mediated Wnt/β-catenin and mTORC1 signaling.

Journal: Leukemia & lymphoma
Published: April 24, 2023

Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B-cell lymphoma.

Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B-cell lymphoma.

Journal: Cancer
Published: May 23, 2022

MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model.

MCRT, a multifunctional ligand of opioid and neuropeptide FF receptors, attenuates neuropathic pain in spared nerve injury model.

Journal: Basic & clinical pharmacology & toxicology
Published: October 03, 2020

Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.

Studies on the changes of uPA system in a co-culture model of bone marrow stromal cells-leukemia cells.

Journal: Bioscience reports
Published: November 27, 2019

AML‑derived mesenchymal stem cells upregulate CTGF expression through the BMP pathway and induce K562‑ADM fusiform transformation and chemoresistance.

AML‑derived mesenchymal stem cells upregulate CTGF expression through the BMP pathway and induce K562‑ADM fusiform transformation and chemoresistance.

Journal: Oncology reports
Published: November 27, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026